MoleculeDx
For Patients
Understand your risk, the blood draw process, and what a molecular screening result can mean.
Who should consider HCC surveillance?
People with cirrhosis and selected patients with chronic hepatitis B or C may benefit from regular surveillance. Eligibility depends on individual risk and professional guidance.
Step-by-step testing
- Start an order using the secure booking portal.
- Provide necessary booking details and complete payment.
- Arrange mobile blood collection, where available.
- Your specimen is transported for laboratory analysis.
- Receive and review results according to the reporting process.
Reporting time can vary with specimen transportation, laboratory processing, and review. Your booking information will provide the current instructions and reporting arrangements.
Understanding results
Results require interpretation with your healthcare professional. Do not stop recommended liver cancer surveillance because of a negative molecular screening result.
Ready to learn more?
Discuss appropriate HCC surveillance with your healthcare professional. Start an order through the secure MoleculeDx booking portal.